Kurum Yazarı "Bilgen, Türker" PubMed İndeksli Yayın Koleksiyonu İçin Listeleme
-
Alloreactive memory B cell detection by flow cytometric cross match using polyclonally activated memory B cell culture supernatants
Akalan, Hande; Şirin, Duygu Yaşar; Yılmaz, İpek; Ata, Pınar; Kara, Veli Melih; Taşdemir, Nicel; Bilgen, Türker; Titiz, Mesut İzzet (Elsevier, 2022)In addition to alloantibodies, alloreactive memory B cell (mBC) evaluation has a potential for immunological risk assessment during transplantation processes. For the alloreactive mBCs evaluation currently, direct Flow ... -
Comparison of Cytotoxic Flow Cytometric Cross Match With Complement Dependent Lymphocytotoxicity and Flow Cytometric Cross Match in Renal Transplant Patients
Bilgen, Türker; Canbakan, Mustafa; Şahin, G.; Titiz, Mesut İzzet (Elsevier USA, 2019)Cytotoxic flow cytometric crossmatch (cFCXM), identified by detecting complement-mediated cytotoxic cell death in addition to the capability of showing the alloantibodies binding onto lymphocytes at the same time, can ... -
Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma
Routila, Johannes; Bilgen, Türker; Saramaki, Outi; Grenman, Reidar; Visakorpi, Tapio; Westermarck, Jukka; Ventela, Sami (Wiley, 2016)BackgroundCIP2A, an inhibitor of PP2A tumour suppressor function, is a widely overexpressed biomarker of aggressive disease and poor therapy response in multiple human cancer types. MethodsCIP2A and DPPA4 copy number ... -
Cytotoxic Antibody Detection by Means of Flow-Cytometric Cross-Match
Bilgen, Türker; Ata, P.; Tozkir, J.; Tozkır, Hilmi; Titiz, Mesut İzzet (Elsevier Science Inc, 2017)Background. Complement-dependent lymphocytotoxicity (CDC-XM) and flowcytometric (FCXM) cross-match are analyzed individually for each donor and recipient pair, because these techniques have fundamental differences for the ... -
Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
Yeşilaltay, Alpay; Değirmenci, Hasan; Bilgen, Türker; Şirin, Duygu Yaşar; Bayır, Duygu; Değirmenci, Pelin; Turgut, Burhan (Lippincott Williams & Wilkins, 2022)Background: We have aimed at exposing left ventricular diastolic functions and the presence of known genetic mutations for familial erythrocytosis, in patients who exhibit idiopathic erythrocytosis. Methods: Sixty-four ... -
First observation of hemoglobin G-waimanalo and hemoglobin fontainebleau cases in the Turkish population
Canatan, D.; Bilgen, Türker; Çiftçi, V.; Yazıcı, G.; Delibaş, S.; Keser, İ. (Turkish Society of Hematology, 2016)[No abstract available] -
First Observation of Hemoglobin Kansas [beta 102(G4)Asn -> Thr, AAC > ACC] in the Turkish Population
Keser, İbrahim; Öztaş, Alev; Bilgen, Türker; Canatan, Duran (Galenos Yayincilik, 2015)[No Abstract Available] -
Gap-PCR Screening for Common Large Deletional Mutations of beta-Globin Gene Cluster Revealed a Higher Prevalence of the Turkish Inversion/Deletion (delta beta)(0) Mutation in Antalya
Bilgen, Türker; Clark, Özden Altıok; Öztürk, Zeynep; Yesilipek, M. Akif; Keser, İbrahim (Galenos Yayincilik, 2016)Objective: Although the calculated carrier frequency for point mutations of the beta-globin gene is around 10% for Antalya Province, nothing is known about the profile of large deletional mutations involving the beta-globin ... -
A Novel Mutation in the Promoter Region of the -Globin Gene: HBB: c.-127G > C
Bilgen, Türker; Canatan, Duran; Delibas, Serpil; Keser, İbrahim (Taylor & Francis Ltd, 2016)Novel -globin gene mutations are still occasionally being reported, especially when evaluating milder phenotypes. We report here a novel putative mutation in the promoter region of the -globin gene and assess its clinical ... -
Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line
Şeber, Erdoğan Selçuk; Şirin, Duygu Yaşar; Yetişyiğit, Tarkan; Bilgen, Türker (Wolters Kluwer Medknow Publications, 2020)Objective: Piperlongumine (PL) is an alkaloid derived from the edible pepper (Piper longum L) and it has been described to have various biologic activities including anticancer effects. Our aim in this study was to assess ...